Tag : launch

Latest News

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

Newsemia
Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis. Source link...
Latest News

Dr. Reddy’s Laboratories Announces First-to-Market Launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market

Newsemia
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”)...
Latest News

Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures

Newsemia
OSAKA, Japan & AMSTERDAM–(BUSINESS WIRE)–Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter “Shionogi”), today announce the launch of Mulpleo® (lusutrombopag) in the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy